Effect of short-course high-dose methylprednisolone treatment on serum IL-2 levels in children with myelodysplastic syndromes: a pilot study.
暂无分享,去创建一个
[1] E. Kansu,et al. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. , 1996, Experimental hematology.
[2] H. Sakamaki,et al. Plasma soluble interleukin‐2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcome , 1996, British journal of haematology.
[3] M. Çetin,et al. Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone. , 1996, Leukemia research.
[4] M. Çetin,et al. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes. , 1995, Hematologic pathology.
[5] A. Tuncer,et al. The potential role of high-dose methylprednisolone on the maturation of leukemic cells in children with acute promyelocytic leukemia (APL) , 1993, Experimental hematology.
[6] H. Zwierzina,et al. Detection of soluble IL‐2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM‐CSF , 1991, British journal of haematology.
[7] Ş. Ozsoylu,et al. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential. , 1991, Leukemia research.
[8] S. Murphy,et al. Lymphocyte interleukin 2 production and responsiveness are altered in patients with primary myelodysplastic syndrome. , 1987, Blood.
[9] P. Nowell,et al. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. , 1986, Journal of immunology.
[10] G. Bagby,et al. Mechanisms of glucocorticosteroid activity in patients with the preleukemic syndrome (hemopoietic dysplasia). , 1980, Leukemia research.
[11] L. Sachs,et al. THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPY , 1978, British journal of haematology.